Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic and epigenetic alterations of myeloproliferative disorders.

International journal of hematology - 1 Feb 2013

Milosevic Jelena D, Kralovics Robert

Abstract excerpt

The classical BCR-ABL negative myeloproliferative neoplasms (MPN) polycythemia vera, essential thrombocythemia, and primary myelofibrosis are clonal hematopoietic disorders characterized by excessive production of terminally differentiated myeloid cells. In MPN patients, the disease can progress to secondary myelofibrosis or acute myeloid leukemia. Clonal hematopoiesis, disease phenotype, and progression are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Receptors, Thrombopoietin
Share to Dioxygenases
Share to DNA (Cytosine-5-)-Methyltransferases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA Methyltransferase 3A

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Polycomb Repressive Complex 2

Share to Proto-Oncogene Proteins c-cbl

Source

Identifiers

PMID: 23233154
DOI: 10.1007/s12185-012-1235-2

Genes

BCR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic and epigenetic alterations of myeloproliferative disorders.PMID 23233154Read ↗

Mutations in myeloproliferative neoplasms - their significance and clinical use.Semantic proximity Read ↗

Genetic basis of MPN: Beyond JAK2-V617F.Semantic proximity Read ↗

Myeloproliferative Neoplasms: Contemporary Review and Molecular Landscape.Semantic proximity Read ↗

Myeloproliferative neoplasms: updates on molecular pathophysiology, diagnosis and treatment strategies.Semantic proximity Read ↗

Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications.Semantic proximity Read ↗

MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation and their Effect on Treatment.Semantic proximity Read ↗

Pathogenesis of Myeloproliferative DisordersSemantic proximity Read ↗

World Health Organization Classification, Evaluation, and Genetics of the Myeloproliferative Neoplasm VariantsSemantic proximity Read ↗

Molecular basis and clonal evolution of myeloproliferative neoplasms.Semantic proximity Read ↗

Molecular pathogenesis of the myeloproliferative neoplasms.Semantic proximity Read ↗

Molecular and genetic bases of myeloproliferative disorders: questions and perspectives.Semantic proximity Read ↗

Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.